RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/35181688http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/35181688http://www.w3.org/2000/01/rdf-schema#comment"Rheumatoid arthritis (RA)-associated interstitial lung disease (RA-ILD) is the most common pulmonary complication of RA, increasing morbidity and mortality. Anti-citrullinated protein antibodies have been associated with the development and progression of both RA and fibrotic lung disease; however, the role of protein citrullination in RA-ILD remains unclear. Here, we demonstrate that the expression of peptidylarginine deiminase 2 (PAD2), an enzyme that catalyzes protein citrullination, is increased in lung homogenates from subjects with RA-ILD and their lung fibroblasts. Chemical inhibition or genetic knockdown of PAD2 in RA-ILD fibroblasts attenuated their activation, marked by decreased myofibroblast differentiation, gel contraction, and extracellular matrix gene expression. Treatment of RA-ILD fibroblasts with the proteoglycan syndecan-2 (SDC2) yielded similar antifibrotic effects through regulation of PAD2 expression, phosphoinositide 3-kinase/Akt signaling, and Sp1 activation in a CD148-dependent manner. Furthermore, SDC2-transgenic mice exposed to bleomycin-induced lung injury in an inflammatory arthritis model expressed lower levels of PAD2 and were protected from the development of pulmonary fibrosis. Together, our results support a SDC2-sensitive profibrotic role for PAD2 in RA-ILD fibroblasts and identify PAD2 as a promising therapeutic target of RA-ILD."xsd:string
http://purl.uniprot.org/citations/35181688http://purl.org/dc/terms/identifier"doi:10.1038/s41598-022-06678-7"xsd:string
http://purl.uniprot.org/citations/35181688http://purl.uniprot.org/core/author"Liang X."xsd:string
http://purl.uniprot.org/citations/35181688http://purl.uniprot.org/core/author"Sun B."xsd:string
http://purl.uniprot.org/citations/35181688http://purl.uniprot.org/core/author"Xiong K."xsd:string
http://purl.uniprot.org/citations/35181688http://purl.uniprot.org/core/author"Robertson M.J."xsd:string
http://purl.uniprot.org/citations/35181688http://purl.uniprot.org/core/author"Perrella M.A."xsd:string
http://purl.uniprot.org/citations/35181688http://purl.uniprot.org/core/author"Romero F."xsd:string
http://purl.uniprot.org/citations/35181688http://purl.uniprot.org/core/author"Rosas I.O."xsd:string
http://purl.uniprot.org/citations/35181688http://purl.uniprot.org/core/author"Poli F."xsd:string
http://purl.uniprot.org/citations/35181688http://purl.uniprot.org/core/author"Ho I.C."xsd:string
http://purl.uniprot.org/citations/35181688http://purl.uniprot.org/core/author"Beeton C."xsd:string
http://purl.uniprot.org/citations/35181688http://purl.uniprot.org/core/author"Doyle T.J."xsd:string
http://purl.uniprot.org/citations/35181688http://purl.uniprot.org/core/author"Cardenas R."xsd:string
http://purl.uniprot.org/citations/35181688http://purl.uniprot.org/core/author"Ryter S.W."xsd:string
http://purl.uniprot.org/citations/35181688http://purl.uniprot.org/core/author"Tsoyi K."xsd:string
http://purl.uniprot.org/citations/35181688http://purl.uniprot.org/core/author"Chu S.G."xsd:string
http://purl.uniprot.org/citations/35181688http://purl.uniprot.org/core/author"Esposito A.J."xsd:string
http://purl.uniprot.org/citations/35181688http://purl.uniprot.org/core/author"Celada L.J."xsd:string
http://purl.uniprot.org/citations/35181688http://purl.uniprot.org/core/author"Bowen R.G."xsd:string
http://purl.uniprot.org/citations/35181688http://purl.uniprot.org/core/author"El-Chemaly S.Y."xsd:string
http://purl.uniprot.org/citations/35181688http://purl.uniprot.org/core/date"2022"xsd:gYear
http://purl.uniprot.org/citations/35181688http://purl.uniprot.org/core/name"Sci Rep"xsd:string
http://purl.uniprot.org/citations/35181688http://purl.uniprot.org/core/pages"2847"xsd:string